Bases bibliographiques Pascal et Francis

Aide

Résultats de votre recherche

Votre recherche

au.\*:("MOUNIER, Nicolas")

Année de publication [py]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Discipline (document) [di]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Pays auteur

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 25 sur 54

  • Page / 3
Export

Sélection :

  • et

Particularités du lymphome de Hodgkin : Lymphomes = Particularities of Hodgkin's lymphoma : LymphomasMOUNIER, Nicolas; FERME, Christophe.La Revue du praticien (Paris). 2010, Vol 60, Num 1, pp 75-79, issn 0035-2640, 5 p.Article

Anticorps monoclonaux dans le traitement des lymphomes : Lymphomes de l'adulte = Monoclonal antibodies in the treatment of lymphoma : Lymphomas in the adultMOUNIER, Nicolas; GISSELBRECHT, Christian.La Revue du praticien (Paris). 2002, Vol 52, Num 9, pp 982-985, issn 0035-2640Article

Modern management of non-Hodgkin lymphoma in HIV-infected patientsMOUNIER, Nicolas; SPINA, Michele; GISSELBRECHT, Christian et al.British journal of haematology. 2007, Vol 136, Num 5, pp 685-698, issn 0007-1048, 14 p.Article

Improving second-line therapy in aggressive non-Hodgkin's lymphomaGISSELBRECHT, Christian; MOUNIER, Nicolas.Seminars in oncology. 2004, Vol 31, pp 12-16, issn 0093-7754, 5 p., SUP2Article

Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphomaGISSELBRECHT, Christian; MOUNIER, Nicolas.Seminars in oncology. 2003, Vol 30, Num 1, pp 28-33, issn 0093-7754, 6 p., SUP2Article

Activité clinique du CCI779 (temsirolimus), inhibiteur de mTOR = Update on clinical activity of CCI779 (temsirolimus), mTOR inhibitorMOUNIER, Nicolas; VIGNOT, Stéphane; SPANO, Jean-Philippe et al.Bulletin du cancer. 2006, Vol 93, Num 11, pp 1139-1143, issn 0007-4551, 5 p.Article

High-dose therapy for indolent lymphomaMOUNIER, Nicolas; SOCIE, Gérard; GISSELBRECHT, Christian et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 225-239, issn 1040-8428Article

Féminité et cancer du sein, approche particulière de l'annonce en cancérologie = Femininity and breast cancer, original approach of announcement in oncologyBAIZE, Nathalie; MOUNIER, Nicolas; BONGAIN, André et al.Bulletin du cancer. 2008, Vol 95, Num 9, pp 849-857, issn 0007-4551, 9 p.Article

Protéines kinases C : une nouvelle cible cytoplasmique = Protein kinases C : a new cytoplasmic targetVIGNOT, Stéphane; SORIA, Jean-Charles; SPANO, Jean-Philippe et al.Bulletin du cancer. 2008, Vol 95, Num 7-8, pp 683-689, issn 0007-4551, 7 p.Article

VIH et cancer: état des connaissances = HIV-related malignancies: state of artGOBERT, Aurélien; MOUNIER, Nicolas; LAVOLE, Armelle et al.Bulletin du cancer. 2014, Vol 101, Num 11, pp 1020-1029, issn 0007-4551, 10 p.Article

Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma : A GELA StudySEBBAN, Catherine; BRICE, Pauline; COIFFIER, Bertrand et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3614-3620, issn 0732-183X, 7 p.Article

CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients : A study by the groupe d'etude des lymphomes de l'adulteBONNET, Christophe; FILLET, Georges; TILLY, Hervé et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 787-792, issn 0732-183X, 6 p.Article

Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma : A study from the groupe d'etude des lymphomes de l'adulteCASASNOVAS, Rend-Olivier; MOUNIER, Nicolas; BIENVENU, Jacques et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1732-1740, issn 0732-183X, 9 p.Article

Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-hodgkin lymphoma patientsRUIZ-SOTO, Rodrigo; SERGENT, Guillaume; GISSELBRECHT, Christian et al.Cancer. 2005, Vol 104, Num 12, pp 2735-2742, issn 0008-543X, 8 p.Article

Efficacy and Toxicity of 2 Schedules of Frontline Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Plus Bortezomib in Patients With B-Cell Lymphoma: A Randomized Phase 2 Trial From the French Adult Lymphoma Study Group (GELA)RIBRAG, Vincent; GISSELBRECHT, Christian; HAIOUN, Corinne et al.Cancer. 2009, Vol 115, Num 19, pp 4540-4546, issn 0008-543X, 7 p.Article

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma : the GELF-94 randomized study from the groupe d'etude des lymphomes de l'adulte (GELA). CommentaryVAN BESIEN, Koen; SEBBAN, Catherine; DOYEN, Chantal et al.Blood. 2006, Vol 108, Num 8, issn 0006-4971, 2496-2497,2540-2544 [7 p.]Article

Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosisFARGE, Dominique; HENEGAR, Corneliu; BENGOUFA, Djaouida et al.Arthritis and rheumatism. 2005, Vol 52, Num 5, pp 1555-1563, issn 0004-3591, 9 p.Article

MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantationCUCCUINI, Wendy; BRIERE, Josette; SOULIER, Jean et al.Blood. 2012, Vol 119, Num 20, pp 4619-4624, issn 0006-4971, 6 p.Article

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab EraGISSELBRECHT, Christian; GLASS, Bertram; MA, David et al.Journal of clinical oncology. 2010, Vol 28, Num 27, pp 4184-4190, issn 0732-183X, 7 p.Article

VEGF and VEGFR-1 Are Coexpressed by Epithelial and Stromal Cells of Renal Cell CarcinomaRIVET, Jacqueline; MOURAH, Samia; MURATA, Hideyuki et al.Cancer. 2008, Vol 112, Num 2, pp 433-442, issn 0008-543X, 10 p.Article

High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma : A study using patients as their own controlsVIGNOT, Stéphane; MOUNIER, Nicolas; LARGHERO, Jérome et al.Cancer. 2007, Vol 109, Num 1, pp 60-67, issn 0008-543X, 8 p.Conference Paper

Pathologic and clinical features of 77 hodgkin's Lymphoma patients treated in a lymphoma protocol (LNH87): a GELA studyCAZALS-HATEM, Dominique; ANDRE, Marc; DIEBOLD, Jacques et al.The American journal of surgical pathology. 2001, Vol 25, Num 3, pp 297-306, issn 0147-5185Article

Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patientsLEFRERE, François; BASTIT-BARRAU, Dominique; FORNECKER, Luc et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 1, pp 115-122, issn 0041-1132, 8 p.Article

Breast cancer among HIV infected individuals from the ONCOVIH study, in France: Therapeutic implicationsPHILIPPE SPANO, Jean; LANOY, Emilie; MOUNIER, Nicolas et al.European journal of cancer (1990). 2012, Vol 48, Num 18, pp 3335-3341, issn 0959-8049, 7 p.Article

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive LymphomaGISSELBRECHT, Christian; SCHMITZ, Norbert; SHPILBERG, Ofer et al.Journal of clinical oncology. 2012, Vol 30, Num 36, pp 4462-4469, issn 0732-183X, 8 p.Article

  • Page / 3